StonvexLoading…
StonvexStonvexStonvexCore line items from SCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $604.51M | $2.33B | $1.78B | $1.19B |
Operating Income | $-49.62M | $78.55M | $68.05M | $46.25M |
Net Income | $-41.41M | $46.90M | $41.89M | $31.05M |
EPS (Diluted) | $-1.81 | $2.05 | $1.83 | $1.36 |
Total Assets | $2.33B | $2.36B | $2.43B | $2.42B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $140.78M | $132.69M | $118.54M | $88.90M |
Free Cash Flow OCF − CapEx | $-13.95M | $25.37M | $-5.00K | $-40.21M |
Shares Outstanding | 22.89M | 22.89M | 22.89M | 22.89M |